Can a less invasive surgery plus radiation match major surgery for rectal cancer?

NCT ID NCT04098471

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial compares two treatments for people with early-stage (T2) rectal cancer located near the anus. One group receives a less invasive procedure called transanal local excision followed by radiotherapy, while the other group undergoes standard major surgery (total mesorectal excision). The goal is to see whether the less invasive approach can achieve similar cancer control and survival rates while possibly offering better quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transanal local excision following radiotherapy or total mesorectal excision
What this could lead to
If successful, this could show that a less invasive surgery combined with radiotherapy is as effective as major surgery for early rectal cancer, potentially preserving quality of life.
What could go wrong
This is a mid-stage trial with 168 participants, so results may not apply to all patients. The less invasive approach might carry a higher risk of cancer recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Colorectal Surgery Department, First Affiliated Hospital of Nanjing Medical University

    RECRUITING

    Nanjing, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.